Injective explodiert: 21Shares beantragt SEC-Zulassung für bahnbrechenden INJ ETF
Der DeFi-Markt steht Kopf: Injective Protocol erlebt einen massiven Momentum-Schub, während 21Shares offiziell die SEC-Genehmigung für den ersten INJ-ETF beantragt.
Regulatorischer Meilenstein
Der Antrag markiert einen Wendepunkt für den gesamten Kryptosektor - traditionelle Finanzinstrumente öffnen sich endlich für fortschrittliche DeFi-Protokolle. Während sich die SEC traditionell mit Bitcoin- und Ethereum-ETFs beschäftigt hat, könnte dieser Vorstoß die Tür für eine neue Generation von Krypto-Investmentprodukten öffnen.
Injective's Aufstieg
Das Protokoll profitiert von perfektem Timing: DeFi-Nachfrage trifft auf institutionelles Interesse. Die native INJ-Tokenomics mit Staking-Mechanismen und Governance-Funktionen positionieren das Projekt ideal für ETF-Strukturen - etwas, das traditionelle Finanzanalysten bisher übersehen haben.
21Shares' strategischer Zug
Der ETF-Pionier erkennt das Potenzial von spezialisierten DeFi-Investments, während andere Anbieter noch mit Standard-Krypto-ETFs kämpfen. Ein kluger Schachzug in einem Markt, der nach Differenzierung hungert.
Die große Frage: Wird die SEC mitspielen oder bleibt sie in ihrer konservativen Komfortzone gefangen? Während traditionelle Banker noch über Blockchain-Technologie diskutieren, bauen kluge Investoren bereits die Infrastruktur von morgen.
21Shares aims to provide investors with direct INJ exposure
🚨 BREAKING: 21Shares just filed for a new $INJ ETF.
This is a major signal of growing institutional interest, making $INJ one of the few digital assets with multiple ETF products in progress.@21Shares is among the world’s largest exchange traded product issuers. pic.twitter.com/xjWSZJVmsT
— Injective 🥷 (@injective) October 20, 2025
The company revealed in its October 20 filing with the U.S. SEC that the proposed INJ ETF will provide investors with direct INJ exposure. The ETF will hold physical INJ tokens in cold storage custody, and its regulated third-party custodians will be the Coinbase Custody Trust Company, LLC, and BitGo Trust Company Inc.
CoinGecko data showed that Injective’s trading volume surged 5.4% in 24 hours, hitting $79.4 million, indicating increased market activity. INJ’s price is currently $8.80, but it has ranged between $7.81 and $10.04 over the past week.
Meanwhile, staking has reportedly remained strong even after price dips, signaling steady INJ holders’ confidence in the token’s future. The crypto community has also confirmed that retail and institutional participants are closely watching the token’s development. One crypto commentator noted on X that multiple ETF filings reflect increasing trust in INJ by institutions. The ensuing discussion reveals that Injective’s ecosystem is strongly supported by its committed user base.
21Shares’ application for an INJ ETF also represents growing interest in L1 blockchains. News about the application is also boosting the token’s market visibility and sentiment. The 21Shares team believes the industry should anticipate INJ access via their INJ ETF in the coming months. However, the Trust will not invest in derivatives.
21Shares’ filing strengthens INJ’s market position
The injective blockchain is reportedly gaining attention due to its rising institutional interest and fast growth. The network’s team claims the L1 blockchain processes over 25,000 transactions per second using DPoS (delegated proof-of-stake) consensus.
The Injective Council recently held its first meeting, which focused on improving the ecosystem’s strategic goals and governance. 21Shares said its ETF filing aligns with these expansion efforts, boosting Injective’s standing among established blockchains. The ETP issuer also believes long-term demand for INJ could increase as institutions continue to explore the crypto asset.
The 21Shares team noted that investors are weighing staking opportunities as they evaluate INJ performance alongside potential ETF inflows. Meanwhile, the token’s price data and rising ETF interest signal new trading dynamics in the crypto industry. Institutional filings are also driving short-term liquidity spikes that encourage holders to increase INJ exposure or staking.
However, the team warned that no INJ exchange is immune to risks, although the Trust does not buy or sell INJ on spot markets. The closure or temporary shutdown of INJ exchanges due to business failure, fraud, government-mandated regulation, or hackers and malware can reduce confidence in the Injective network or slow down mass adoption. The failure of spot markets or any other major component of the INJ ecosystem can result in adverse effects on INJ markets and could, therefore, negatively impact the Trust’s performance.
Further, the team believes negative perceptions and customers’ manipulation of INJ spot markets may generally reduce confidence in INJ, resulting in greater INJ price volatility. The nature of the assets held at INJ spot markets also makes them appealing targets for hackers, and a few INJ spot markets have reportedly been cybercrime victims.
Sign up to Bybit and start trading with $30,050 in welcome gifts
